Table 2.

Incidence rates of classical Hodgkin lymphoma (HL) overall and by selected histologic subtype, for US- and foreign-born Hispanics, and nativity incidence rate ratios (IRR) and 95 % confidence intervals (CI), by gender and age, 1988–2004, California

	All HL								Nodular sclerosis HL								Mixed cellularity HL
	US-born Hispanics			Foreign-born Hispanics			US-born vs. Foreign born		US-born Hispanics			Foreign-born Hispanics			US-born vs. Foreign-born		US-born Hispanics			Foreign-born Hispanics			US-born vs. Foreign-born
	N	Rate*	95% CI	N	Rate*	95% CI	IRR	95% CI	N	Rate*	95% CI	N	Rate*	95% CI	IRR	95% CI	N	Rate*	95% CI	N	Rate*	95% CI	IRR	95% CI
TOTALS
Age (10-year groups)
00–09	105	0.34	0.28–0.41	29	0.71	0.48–1.04	0.47	0.31–0.74	67	0.22	0.17–0.28	10	0.27	0.13–0.51	0.81	0.40–1.77	30	0.10	0.06–0.14	14	0.33	0.18–0.57	0.29	0.15–0.59
10–19	356	1.73	1.55–1.92	109	1.26	1.03–1.53	1.37	1.10–1.72	280	1.37	1.21–1.54	80	0.92	0.73–1.15	1.48	1.15–1.94	41	0.19	0.14–0.26	13	0.17	0.09–0.29	1.12	0.59–2.32
20–29	439	3.16	2.87–3.47	209	1.12	0.97–1.28	2.83	2.40–3.36	326	2.35	2.10–2.62	148	0.79	0.67–0.93	2.96	2.43–3.62	56	0.40	0.30–0.51	37	0.19	0.14–0.27	2.04	1.32–3.19
30–39	250	2.57	2.26–2.92	165	0.87	0.74–1.01	2.96	2.41–3.63	177	1.81	1.55–2.10	101	0.53	0.43–0.64	3.43	2.67–4.45	43	0.44	0.32–0.60	36	0.19	0.14–0.27	2.27	1.41–3.66
40–49	140	2.29	1.93–2.70	114	1.00	0.83–1.21	2.28	1.77–2.95	76	1.24	0.97–1.55	51	0.44	0.33–0.58	2.79	1.93–4.06	34	0.57	0.39–0.80	35	0.31	0.22–0.44	1.81	1.10–3.00
50–59	95	2.60	2.10–3.18	127	2.17	1.81–2.58	1.20	0.91–1.58	43	1.18	0.85–1.59	43	0.73	0.53–0.99	1.60	1.03–2.51	25	0.68	0.44–1.01	47	0.80	0.59–1.06	0.85	0.50–1.42
60–69	104	3.98	3.25–4.83	103	3.38	2.76–4.10	1.18	0.89–1.56	26	1.00	0.65–1.46	36	1.17	0.82–1.63	0.85	0.49–1.45	42	1.61	1.16–2.18	43	1.42	1.03–1.92	1.13	0.72–1.78
70–79	72	4.67	3.65–5.90	99	6.17	5.01–7.52	0.76	0.55–1.04	25	1.64	1.06–2.43	29	1.82	1.22–2.62	0.90	0.50–1.60	23	1.42	0.90–2.14	33	2.05	1.41–2.88	0.69	0.39–1.22
80+	24	4.22	2.69–6.32	55	6.65	5.01–8.65	0.64	0.37–1.05	10	1.75	0.83–3.27	20	2.41	1.47–3.73	0.73	0.30–1.65	10	1.75	0.83–3.27	19	2.30	1.38–3.59	0.76	0.31–1.75
Age groups
00–14	227	0.56	0.49–0.64	71	0.90	0.70–1.15	0.62	0.47–0.83	155	0.39	0.33–0.45	40	0.49	0.34–0.68	0.80	0.55–1.18	53	0.13	0.10–0.17	22	0.30	0.19–0.46	0.43	0.25–0.74
15–39	923	2.77	2.58–2.96	441	1.04	0.94–1.15	2.66	2.36–3.01	695	2.05	1.90–2.22	299	0.71	0.63–0.80	2.89	2.51–3.35	117	0.37	0.31–0.45	78	0.17	0.14–0.22	2.15	1.58–2.93
40–54	189	2.32	2.00–2.68	171	1.19	1.02–1.38	1.96	1.58–2.42	99	1.21	0.98–1.47	71	0.48	0.38–0.61	2.50	1.82–3.46	47	0.59	0.43–0.79	58	0.42	0.31–0.54	1.42	0.94–2.13
55+	246	3.95	3.46–4.50	327	4.54	4.04–5.08	0.87	0.73–1.04	81	1.35	1.06–1.69	108	1.49	1.21–1.82	0.90	0.66–1.23	87	1.38	1.10–1.72	119	1.63	1.34–1.97	0.85	0.63–1.14
TOTAL	####	2.45	2.31–2.60	####	1.79	1.66–1.92	1.37	1.25–1.51	1,030	1.36	1.26–1.47	518	0.78	0.70–0.86	1.75	1.53–1.99	304	0.58	0.51–0.67	277	0.56	0.49–0.65	1.03	0.85–1.25
MALES
Age (10-year groups)
00–09	81	0.51	0.41–0.64	19	0.91	0.54–1.44	0.57	0.34–0.99	51	0.33	0.24–0.43	6	0.31	0.11–0.69	1.05	0.44–3.03	25	0.16	0.10–0.23	11	0.51	0.25–0.93	0.31	0.14–0.70
10–19	184	1.73	1.48–1.99	59	1.29	0.97–1.68	1.34	0.98–1.85	136	1.28	1.07–1.52	39	0.83	0.58–1.15	1.55	1.06–2.30	26	0.24	0.15–0.35	11	0.27	0.13–0.49	0.87	0.41–1.99
20–29	210	2.90	2.52–3.33	133	1.24	1.04–1.47	2.34	1.87–2.93	135	1.87	1.56–2.21	82	0.77	0.61–0.96	2.41	1.82–3.22	42	0.57	0.41–0.77	33	0.30	0.21–0.43	1.88	1.16–3.07
30–39	115	2.35	1.94–2.83	104	1.02	0.83–1.24	2.31	1.75–3.06	70	1.43	1.11–1.82	61	0.60	0.45–0.77	2.40	1.67–3.46	26	0.51	0.33–0.76	25	0.25	0.16–0.36	2.09	1.15–3.81
40–49	80	2.67	2.12–3.33	71	1.23	0.96–1.55	2.17	1.55–3.03	40	1.33	0.95–1.81	29	0.50	0.34–0.72	2.65	1.60–4.44	24	0.82	0.53–1.22	24	0.43	0.27–0.64	1.92	1.04–3.53
50–59	56	3.17	2.40–4.12	74	2.64	2.07–3.32	1.20	0.83–1.72	23	1.30	0.82–1.95	20	0.71	0.43–1.10	1.83	0.96–3.52	15	0.85	0.48–1.40	23	0.82	0.52–1.23	1.04	0.50–2.07
60–69	64	5.24	4.04–6.70	59	4.32	3.28–5.58	1.21	0.84–1.76	17	1.39	0.81–2.22	22	1.60	1.00–2.44	0.87	0.43–1.71	23	1.89	1.20–2.84	21	1.56	0.96–2.38	1.22	0.64–2.32
70–79	44	6.58	4.76–8.88	52	8.03	5.98–10.55	0.82	0.53–1.26	13	1.96	1.03–3.38	14	2.15	1.17–3.62	0.91	0.39–2.11	16	2.25	1.28–3.69	18	2.80	1.65–4.44	0.80	0.38–1.69
80+	9	4.37	1.96–8.51	31	10.22	6.94–14.51	0.43	0.18–0.94	5	2.65	0.83–6.33	10	3.32	1.59–6.10	0.80	0.21–2.62	<5	1.29	0.27–4.08	14	4.57	2.50–7.67	0.28	0.05–1.09
Age groups
00–14	152	0.73	0.62–0.85	43	1.07	0.77–1.47	0.68	0.47–0.99	100	0.48	0.39–0.59	20	0.48	0.29–0.77	1.00	0.60–1.75	39	0.18	0.13–0.25	18	0.47	0.28–0.77	0.38	0.21–0.72
15–39	438	2.55	2.30–2.82	272	1.13	1.00–1.28	2.25	1.91–2.64	292	1.66	1.47–1.88	168	0.71	0.60–0.83	2.34	1.91–2.87	80	0.48	0.38–0.60	62	0.24	0.19–0.32	1.96	1.37–2.82
40–54	109	2.75	2.25–3.32	104	1.44	1.17–1.75	1.91	1.44–2.53	50	1.24	0.92–1.64	39	0.53	0.37–0.72	2.35	1.51–3.69	33	0.85	0.58–1.19	34	0.47	0.33–0.67	1.78	1.07–2.98
55+	144	5.08	4.23–6.05	183	6.09	5.18–7.10	0.83	0.66–1.06	48	1.81	1.29–2.48	56	1.85	1.37–2.45	0.98	0.62–1.52	48	1.64	1.19–2.22	66	2.27	1.73–2.93	0.72	0.48–1.10
TOTAL	843	2.74	2.51–2.99	602	2.24	2.02–2.48	1.22	1.07–1.40	490	1.35	1.19–1.52	283	0.87	0.74–1.01	1.56	1.28–1.90	200	0.74	0.62–0.88	180	0.78	0.64–0.93	0.96	0.74–1.24
FEMALES
Age (10-year groups)
00–09	24	0.16	0.10–0.23	10	0.51	0.24–0.97	0.31	0.14–0.73	16	0.10	0.06–0.17	<5	0.23	0.06–0.60	0.46	0.14–1.94	5	0.03	0.01–0.08	<5	0.14	0.03–0.46	0.23	0.04–1.48
10–19	172	1.73	1.48–2.01	50	1.24	0.91–1.64	1.39	1.01–1.96	144	1.46	1.23–1.72	41	1.03	0.73–1.41	1.41	0.99–2.07	15	0.14	0.08–0.23	<5	0.05	0.01–0.19	2.66	0.61–25.61
20–29	229	3.43	3.00–3.91	76	0.95	0.74–1.19	3.63	2.78–4.78	191	2.86	2.47–3.30	66	0.82	0.63–1.05	3.49	2.62–4.70	14	0.21	0.11–0.35	<5	0.05	0.01–0.12	4.41	1.36–18.67
30–39	135	2.79	2.34–3.31	61	0.70	0.53–0.90	4.02	2.94–5.55	107	2.19	1.79–2.65	40	0.45	0.32–0.61	4.90	3.36–7.27	17	0.37	0.21–0.59	11	0.13	0.07–0.24	2.74	1.21–6.53
40–49	60	1.92	1.47–2.48	43	0.77	0.56–1.04	2.50	1.66–3.80	36	1.15	0.80–1.59	22	0.39	0.24–0.59	2.98	1.70–5.32	10	0.33	0.16–0.61	11	0.20	0.10–0.36	1.66	0.63–4.31
50–59	39	2.07	1.47–2.82	53	1.74	1.30–2.28	1.19	0.76–1.83	20	1.06	0.65–1.64	23	0.76	0.48–1.13	1.41	0.73–2.68	10	0.53	0.25–0.97	24	0.78	0.50–1.17	0.67	0.29–1.46
60–69	40	2.87	2.05–3.91	44	2.62	1.90–3.51	1.10	0.70–1.73	9	0.65	0.30–1.23	14	0.83	0.45–1.39	0.78	0.30–1.94	19	1.36	0.82–2.13	22	1.31	0.82–1.99	1.04	0.53–2.01
70–79	28	3.21	2.13–4.65	47	4.91	3.61–6.54	0.65	0.39–1.07	12	1.39	0.72–2.44	15	1.60	0.89–2.63	0.87	0.37–2.01	7	0.77	0.31–1.60	15	1.55	0.86–2.55	0.50	0.17–1.31
80+	15	4.16	2.32–6.91	24	4.56	2.92–6.78	0.91	0.44–1.82	5	1.32	0.43–3.15	10	1.89	0.91–3.48	0.70	0.19–2.29	7	1.98	0.79–4.12	5	0.95	0.31–2.21	2.09	0.57–8.44
Age groups
00–14	75	0.39	0.31–0.49	28	0.72	0.47–1.07	0.54	0.34–0.88	55	0.29	0.22–0.38	20	0.49	0.29–0.79	0.59	0.33–1.06	14	0.07	0.04–0.12	<5	0.12	0.03–0.32	0.63	0.18–2.66
15–39	485	2.99	2.72–3.29	169	0.92	0.78–1.08	3.25	2.70–3.93	403	2.46	2.21–2.72	131	0.71	0.59–0.85	3.47	2.82–4.30	37	0.26	0.18–0.36	16	0.08	0.05–0.14	3.13	1.66–6.13
40–54	80	1.92	1.52–2.39	67	0.94	0.72–1.19	2.05	1.46–2.89	49	1.18	0.87–1.56	32	0.44	0.30–0.62	2.69	1.68–4.36	14	0.34	0.19–0.58	24	0.35	0.23–0.53	0.98	0.47–1.97
55+	102	3.03	2.46–3.70	1.44	3.47	2.91–4.10	0.87	0.67–1.14	33	1.00	0.68–1.42	52	1.25	0.92–1.64	0.80	0.50–1.28	39	1.15	0.81–1.59	53	1.21	0.90–1.60	0.95	0.60–1.48
TOTAL	742	2.21	2.03–2.41	408	1.43	1.28–1.59	1.55	1.35–1.79	540	1.40	1.27–1.55	235	0.72	0.62–0.83	1.95	1.63–2.34	104	0.43	0.34–0.53	97	0.39	0.31–0.48	1.10	0.80–1.50

^*Rates are per 100,000 and age adjusted to the 2000 US Standard Population (19 age groups–Census P25–1130); confidence intervals (Tiwari modification) are 95 % for rates

Bolded IRR and 95 % CI are statistically significant

To comply with California Cancer Registry confidentiality regulations, case counts fewer than 5 are not presented